- Home
- SNGX vs FIEE Comparison
SNGX vs FIEE Comparison
Compare SNGX & FIEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- FIEE
- Stock Information
- Founded
- SNGX 1987
- FIEE N/A
- Country
- SNGX United States
- FIEE United States
- Employees
- SNGX N/A
- FIEE 43
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- FIEE Telecommunications Equipment
- Sector
- SNGX Health Care
- FIEE Utilities
- Exchange
- SNGX Nasdaq
- FIEE Nasdaq
- Market Cap
- SNGX 13.8M
- FIEE 15.6M
- IPO Year
- SNGX 1987
- FIEE N/A
- Fundamental
- Price
- SNGX $1.34
- FIEE $2.49
- Analyst Decision
- SNGX Strong Buy
- FIEE
- Analyst Count
- SNGX 1
- FIEE 0
- Target Price
- SNGX $6.00
- FIEE N/A
- AVG Volume (30 Days)
- SNGX 697.0K
- FIEE N/A
- Earning Date
- SNGX 11-10-2025
- FIEE N/A
- Dividend Yield
- SNGX N/A
- FIEE N/A
- EPS Growth
- SNGX N/A
- FIEE N/A
- EPS
- SNGX N/A
- FIEE N/A
- Revenue
- SNGX N/A
- FIEE N/A
- Revenue This Year
- SNGX N/A
- FIEE N/A
- Revenue Next Year
- SNGX N/A
- FIEE N/A
- P/E Ratio
- SNGX N/A
- FIEE N/A
- Revenue Growth
- SNGX N/A
- FIEE N/A
- 52 Week Low
- SNGX $1.09
- FIEE N/A
- 52 Week High
- SNGX $6.23
- FIEE N/A
- Technical
- Relative Strength Index (RSI)
- SNGX 34.06
- FIEE 41.19
- Support Level
- SNGX $1.54
- FIEE $2.34
- Resistance Level
- SNGX $1.61
- FIEE $2.52
- Average True Range (ATR)
- SNGX 0.10
- FIEE 0.14
- MACD
- SNGX 0.01
- FIEE 0.01
- Stochastic Oscillator
- SNGX 8.70
- FIEE 38.98
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About FIEE FiEE Inc Common Stock
FiEE Inc, formerly Minim Inc is a digital service provider focused on integrating artificial intelligence and data analytics into content creation and brand management. The company offers a range of services designed to support creators, artists, and businesses in developing, managing, and optimizing their digital presence across various platforms, including customized graphic and posts, short videos, and editorial calendars aligned with brand goals.